Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinobufotalin versus preventive TACE after radical surgery for liver cancer
ChiCTR-TRC-12003167Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of cinobufotalin in hepatocellular carcinoma (HCC) (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Laboratory tests, General condition score (ECOG rating) and 1 more. Started Jan 2012; status: completed.
02
Drugs
cinobufotalin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on ChiCTR-TRC-12003167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12003167.